Cargando…
Risk factors for RhD immunisation in a high coverage prevention programme of antenatal and postnatal RhIg: a nationwide cohort study
OBJECTIVE: To evaluate which risk factors for RhD immunisation remain, despite adequate routine antenatal and postnatal RhIg prophylaxis (1000 IU RhIg) and additional administration of RhIg. The second objective was assessment of the current prevalence of RhD immunisations. DESIGN: Prospective cohor...
Autores principales: | Slootweg, Y. M., Zwiers, C., Koelewijn, J. M., van der Schoot, E., Oepkes, D., van Kamp, I. L., de Haas, M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9543810/ https://www.ncbi.nlm.nih.gov/pubmed/35133072 http://dx.doi.org/10.1111/1471-0528.17118 |
Ejemplares similares
-
Risk factors for RhD immunisation despite antenatal and postnatal anti-D prophylaxis
por: Koelewijn, JM, et al.
Publicado: (2009) -
Is antenatal RhIg completely safe?
por: Subramaniyan, Rajeswari, et al.
Publicado: (2016) -
Women's attitude towards prenatal screening for red blood cell antibodies, other than RhD
por: Koelewijn, JM, et al.
Publicado: (2008) -
Hemolytic disease of the fetus and newborn in the sensitizing pregnancy where anti‐D was incorrectly identified as RhIG
por: Walhof, Mackenzie L., et al.
Publicado: (2022) -
Targeted Routine Antenatal Anti-D Prophylaxis in the Prevention of RhD Immunisation - Outcome of a New Antenatal Screening and Prevention Program
por: Tiblad, Eleonor, et al.
Publicado: (2013)